Decreased in‐hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID‐19-Reference-Cited by-同舟云学术

Decreased in‐hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID‐19

Published:2021-05-08 Issue:9 Volume:93 Page:5390-5395
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Haji Aghajani Mohammad¹,Moradi Omid²^ORCID,Amini Hossein²,Azhdari Tehrani Hamed³,Pourheidar Elham³,Rabiei Mohammad M.⁴^ORCID,Sistanizad Mohammad¹²

Affiliation:

1. Prevention of Cardiovascular Disease Research Center, Imam Hossein Hospital Shahid Beheshti University of Medical Sciences Tehran Iran

2. Department of Clinical Pharmacy, School of Pharmacy Shahid Beheshti University of Medical Sciences Tehran Iran

3. Department of Hematology and Medical Oncology Shahid Beheshti University of Medical Sciences Tehran Iran

4. Clinical Research Development Unit of Loghman Hakim Hospital Shahid Beheshti University of Medical Sciences Tehran Iran

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27053

Reference17 articles.

1. COVID‐19 mortality in patients on anticoagulants and antiplatelet agents

2. Aspirin use is associated with decreased mechanical ventilation, ICU admission, and in‐hospital mortality in hospitalized patients with COVID‐19 [published online ahead of print];Chow JH;Anesth Analg,2020

3. Anticoagulant treatment in COVID-19: a narrative review

4. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management

5. Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Aspirin on Clinical Outcomes of COVID-19: A Meta-Analysis;Advances in Clinical Medicine;2024

2. The Role of Anticoagulants and Antiplatelets in Reducing Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis of Studies Reporting Adjusted Data;Cureus;2023-09-22

3. COVID-19 and non-steroid anti-inflammatory drugs;EMERGENCY MEDICINE;2023-06-25

4. COVID-19 as a polymorphic inflammatory spectrum of diseases: a review with focus on the brain;Acta Neuropsychiatrica;2023-03-02

5. Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents;The Lancet Infectious Diseases;2023-01